In focus
Latest feed
FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment
A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus
Nova Scotia's Innovative SPOT Program: A Game-Changer for Early Skin Cancer Detection
Ben Sasse's Unwavering Resolve: Defying Cancer, Championing America's Future
